Higher osteoclastic demineralization and highly mineralized cement lines with osteocalcin deposition in a mandibular cortical bone of autosomal dominant osteopetrosis type II: Ultrastructural and undecalcified histological investigations

Bone

Volumn 27, Issue 3, 2000, Pages 389-395

  Semba, I ^a   Ishigami, T ^a   Sugihara, K ^a   Kitano, M ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Autosomal dominant osteopetrosis type II; Contact microradiogram; Osteocalcin; Osteoclast; Ultrastructure; Undecalcified preparation

Indexed keywords

OSTEOCALCIN;

ADULT; ALBERS SCHOENBERG DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CELL PROLIFERATION; DEMINERALIZATION; DISEASE ASSOCIATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE; MICRORADIOGRAPHY; OSTEOLYSIS; OSTEOMYELITIS; PROTEIN LOCALIZATION; ULTRASTRUCTURE;

BONE DENSITY; BONE MATRIX; BONE RESORPTION; GENES, DOMINANT; HUMANS; MALE; MANDIBLE; MICROSCOPY, ELECTRON; MIDDLE AGED; OSTEOCALCIN; OSTEOCLASTS; OSTEOMYELITIS; OSTEOPETROSIS;

EID: 0033834243     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00330-6     Document Type: Article

References (48)

1. Albers-Schönberg H. Röntgenbilder einer seltenen Knochenerkrankung. Muenchener Med Wschr. 51:1904;365.
2. Ambler M.W., Trice J., Grauerholz J., O'Shea P.A. Infantile osteopetrosis and neuronal storage disease. Neurology. 33:1983;437-441.
3. Anderson P.E., Bollerslev J. Heterogeneity of autosomal dominant osteopetrosis. Radiology. 164:1987;223-225.
4. Bakeman R.J., Abdelsayed R.A., Sutley S.H., Newhouse R.F. Osteopetrosis A review of the literature and report of a case complicated by osteomyelitis of the mandible . J Oral Maxillofac Surg. 56:1998;1209-1213.
5. Bernard F., Casanova J.L., Cournot G., et al. The protein tyrosine kinase p60c-Src is not implicated in the pathogenesis of the human autosomal recessive form of osteopetrosis A study of 13 children . J Pediatr. 133:1998;537-543.
6. Bollerslev J., Anderson P.E. Jr. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 9:1988;7-13.
7. Bollerslev J., Marks S.C. Jr, Mosekilde L., Lian J.B., Stein G.S., Mosekilde L. Cortical bone osteocalcin content and matrix composition in autosomal dominant osteopetrosis type I. Eur J Endocrinol. 130:1994;592-594.
8. Bollerslev J., Marks S.C. Jr, Pockwinse S., et al. Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone. 14:1993;865-869.
9. Bollerslev J., Nielsen H.K., Larsen H.F., Mosekilde L. Biochemical evidence of disturbed bone metabolism and calcium homeostasis in two types of autosomal dominant osteopetrosis. Acta Med Scand. 224:1988;479-483.
10. Bollerslev J., Steiniche T., Melsen F., Mosekilde L. Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis A study of two radiological types . Bone. 10:1989;19-24.
11. Bollerslev J., Thomas S., Grodum E., Brixen K., Djoseland O. Collagen metabolism in two type of autosomal dominant osteopetrosis during stimulation with thyroid hormones. Eur J Endocrinol. 133:1995;557-563.
12. Brockstedt H., Bollerslev J., Melsen F., Mosekilde L. Cortical bone remodeling in autosomal dominant osteopetrosis A study of two different phenotypes . Bone. 18:1996;67-72.
13. Crofts R.D., Boyce T.M., Bloebaum R.D. Aging changes in osteon mineralization in the human femoral neck. Bone. 15:1994;147-152.
14. Delaissé J.M., Eeckhout Y., Vaes G. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinol. 123:1988;264-276.
15. Denhardt D.T., Noda M. Osteopontin expression and function Role in bone remodeling . J Cell Biochem. 30:(Suppl.):1998;92-102.
16. Dodds R.A., Connor J.R., James I.E., Rykaczewski E.L., Appelbaum E., Dul E., Gowen M. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces An in vitro and ex vivo study of remodeling bone . J Bone Miner Res. 10:1995;1666-1680.
17. Doty S.B., Schofield B.H. Electron microscopic localization of hydrolytic enzymes in osteoclasts. Histochem J. 4:1972;245-258.
18. Ducy P., Desbois C., Boyce B., et al. Increased bone formation in osteocalcin-deficient mice. Nature. 382:1996;448-452.
19. El-Tawil T., Stoker D.J. Benign osteopetrosis A review of 42 cases showing two different patterns . Skel Radiol. 22:1993;587-593.
20. Everts V., Delaissé J.M., Korper W., Niehof A., Vaes G., Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves the participation of both cysteine-proteinases and matrix metaloproteinases. J Cell Physiol. 150:1992;221-231.
21. Fanburg-Smith J.C., Bratthauer G.L., Miettinen M. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma a study of 28 cases . Hum Pathol. 30:1999;32-38.
22. Felix R., Hofstetter W., Cecchini M.G. Recent developments in the understanding of the pathophysiology of osteopetrosis. Eur J Endocrinol. 134:1996;143-156.
23. Gerstenfeld L.C. Osteopontin in skeletal tissue homeostasis An emerging picture of the autocrine/paracrine functions of the extracellular matrix . J Bone Miner Res. 14:1999;850-855.
24. Gothlin G., Ericsson J.L.E. The osteoclast Review of ultrastructure, origin, and structure-function relationship . Clin Orthop. 120:1976;201-231.
25. Gowen M., Lazner F., Dodds R., et al. Cathepsin K knockout mice develop osteopetrosis due to a direct in matrix degradation but not demineralization. J Bone Miner Res. 14:1999;1654-1663.
26. Hauschka P.V., Lian J.B., Gallop P.M. Direct identification of the calcium-binding amino acid, carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA. 72:1975;3925-3929.
27. Helfrich M.H., Aronson D.C., Everts V., et al. Morphologic features of bone in human osteopetrosis. Bone. 12:1991;411-419.
28. Ishigami I., Kawashima K., Yoshida M., et al. A case of bilateral osteomyelitis of the mandible accompanied with osteopetrosis. Jpn J Oral Diagn. 11:1998;137-145.
29. Johnston C.C. Jr, Lavy N., Lord T., Vellios F., Merritt A.D., Deiss W.P. Jr. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine. 47:1968;149-167.
30. Lian J.B., Dunn K., Key L. In vitro degradation of bone particles by human monocytes is decreased with depletion of the vitamin K-dependent bone protein from the matrix. Endocrinology. 118:1986;1636-1642.
31. Lian J.B., Marks S.C. Jr. Osteopetrosis in the rat Coexistence of reductions in osteocalcin and bone resorption . Endocrinology. 126:1990;955-962.
32. Lian J.B., Roufosse A.H., Reit B., Glimcher M.J. Concentrations of osteocalcin and phosphoprotein as a function of mineral content and age in cortical bone. Calcif Tissue Int. 34:(Suppl.):1982;S82-S87.
33. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386:1997;78-84.
34. McKee M.D., Nanci A. Osteopontin and the bone remodeling sequence Colloidal-gold immunocytochemistry of an interfacial extracellular matrix protein . Ann NY Acad Sci. 760:1995;177-189.
35. McKee M.D., Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair . Microsc Res Technol. 33:1996;141-164.
36. Meyerson G., Dahl N., Pahlman S. Malignant osteopetrosis c-src kinase is not reduced in fibroblasts . Calcif Tissue Int. 53:1993;69-70.
37. Osier L.K., Marks S.C. Jr. Osteopetrosis. Rifkin B.R., Gay C.V. Biology and Physiology of the Osteoclast. 1992;433-453 CRC, Boca Raton, FL.
38. Poli V., Balena R., Fattori E., et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. Eur Med Biol Org J. 13:1994;1189-1196.
39. Ritter N.M., Farach-Carson M.C., Butler W.T. Evidence for the formation of a complex between osteopontin and osteocalcin. J Bone Miner Res. 7:1992;877-885.
40. Seifert M.F., Popoff S.N., Jackson M.E., MacKay C.A., Cielinski M., Marks S.C. Jr. Experimental studies of osteopetrosis in laboratory animals. Clin Orthop Rel Res. 294:1993;23-33.
41. Semba I., Matuuchi H., Miura Y. Histomorphometric analysis of osteoclastic bone resorption in jaw bone directly invaded by gingival squamous cell carcinoma. J Oral Pathol Med. 25:1996;429-435.
42. Shalhoub V., Bettencourt B., Jackson M.E., et al. Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations Elevated mRNA transcripts, protein synthesis, and accumulation in bone of mutant animals . J Cell Physiol. 158:1994;110-120.
43. Shapiro F. Osteopetrosis. Current clinical considerations. Clin Orthop Rel Res. 294:1993;34-44.
44. Shapiro F., Key L.L., Anast C. Variable osteoclast appearance in human infantile osteopetrosis. Calcif Tissue Int. 43:1988;67-76.
45. Steiner M., Gould A.R., Means W.R. Osteomyelitis of the mandible associated with osteopetrosis. J Oral Maxillofac Surg. 41:1983;395-405.
46. Van Hul W., Bollerslev J., Gram J., et al. Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet. 61:1997;363-369.
47. Van Tran P., Dryll A., Lansaman J., et al. Osteoclast abnormalities in idiopathic osteopetrosis. Virchows Arch Pathol Anat. 408:1985;269-280.
48. Yoshitake H., Rittling S.R., Denhardt D.T., Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA. 96:1999;8156-8160.